| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
|
Nguyen, Kim-Son H.
|
|
2009
|
10 |
4 |
p. 281-289
9 p.
|
artikel
|
| 2 |
A Decade of Clinical Lung Cancer
|
Gandara, David R.
|
|
2009
|
10 |
4 |
p. 216-
1 p.
|
artikel
|
| 3 |
Cancer Treatments: Can We Find Treasures at the Bottom of the Sea?
|
Provencio, Mariano
|
|
2009
|
10 |
4 |
p. 295-300
6 p.
|
artikel
|
| 4 |
Contralateral Cervicomediastinal Lymph Node Metastases from Clinically Occult Adenocarcinoma of the Lung
|
Hoshikawa, Mayumi
|
|
2009
|
10 |
4 |
p. 249-251
3 p.
|
artikel
|
| 5 |
Developing an Effective Lung Cancer Program in a Community Hospital Setting
|
Fischel, Richard J.
|
|
2009
|
10 |
4 |
p. 239-243
5 p.
|
artikel
|
| 6 |
Development of the Monoclonal Antibody Figitumumab, Targeting the Insulin-like Growth Factor-1 Receptor, for the Treatment of Patients with Non–Small-Cell Lung Cancer
|
Gualberto, Antonio
|
|
2009
|
10 |
4 |
p. 273-280
8 p.
|
artikel
|
| 7 |
Highlights from: The 2009 Annual Meeting of the American Society of Clinical Oncology Orlando, FL May 29-June 2, 2009
|
Xu, Bing-e
|
|
2009
|
10 |
4 |
p. 217-222
6 p.
|
artikel
|
| 8 |
Progress in the Treatment of Metastatic Non–Small-Cell Lung Cancer: Slow but Steady!
|
Ramnath, Nithya
|
|
2009
|
10 |
4 |
p. 260-261
2 p.
|
artikel
|
| 9 |
S-1: A New Oral Fluoropyrimidine in the Treatment of Patients with Advanced Non–Small-Cell Lung Cancer
|
Okamoto, Isamu
|
|
2009
|
10 |
4 |
p. 290-294
5 p.
|
artikel
|
| 10 |
Selected Clinical Trials in Non-Small-Cell Lung Cancer
|
|
|
2009
|
10 |
4 |
p. 257-258
2 p.
|
artikel
|
| 11 |
Skeletal Disease Contributes Substantially to Morbidity and Mortality in Patients with Lung Cancer
|
Hirsh, Vera
|
|
2009
|
10 |
4 |
p. 223-229
7 p.
|
artikel
|
| 12 |
The Rationale and Development of Therapeutic Insulin-like Growth Factor Axis Inhibition for Lung and Other Cancers
|
Camidge, D. Ross
|
|
2009
|
10 |
4 |
p. 262-272
11 p.
|
artikel
|
| 13 |
The Role of Cetuximab in the Management of Non–Small-Cell Lung Cancer
|
Owonikoko, Taofeek K.
|
|
2009
|
10 |
4 |
p. 230-238
9 p.
|
artikel
|
| 14 |
Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
|
Patel, Jyoti D.
|
|
2009
|
10 |
4 |
p. 252-256
5 p.
|
artikel
|
| 15 |
Utility of Integrated Computed Tomography—Positron Emission Tomography for Selection of Operable Malignant Pleural Mesothelioma
|
Wilcox, Brad E.
|
|
2009
|
10 |
4 |
p. 244-248
5 p.
|
artikel
|
Tijdschrift beschrijving